NYSE - Delayed Quote • USD
At close: June 7 at 4:00 PM EDT
After hours: June 7 at 5:45 PM EDT
Line
Candle
Baseline
Mountain
Bar
Loading Chart for LH
9/21 12:03 PM
DELL
Date | |
Close | |
Open | |
High | |
Low | |
Volume |
- Previous Close
198.41 - Open
197.83 - Bid 196.68 x 1100
- Ask 196.78 x 1000
- Day's Range
195.84 - 199.19 - 52 Week Range
186.63 - 234.09 - Volume
456,611 - Avg. Volume
765,890 - Market Cap (intraday)
16.572B - Beta (5Y Monthly) 1.03
- PE Ratio (TTM)
42.01 - EPS (TTM)
4.68 - Earnings Date Jul 25, 2024 - Jul 29, 2024
- Forward Dividend & Yield 2.88 (1.46%)
- Ex-Dividend Date May 28, 2024
- 1y Target Est
239.14
Labcorp Holdings Inc. operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers.
67,000
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Industry
More about Labcorp Holdings Inc.
Recent News: LH
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview: LH
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is
YTD Return
LH
12.90%
S&P 500
12.10%
1-Year Return
LH
6.47%
S&P 500
24.82%
3-Year Return
LH
11.59%
S&P 500
26.41%
5-Year Return
LH
40.81%
S&P 500
88.04%
Compare To: LH
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
196.60
-0.91%
Mkt Cap 16.572B
Industry Diagnostics & Research
142.34
-0.21%
Mkt Cap 15.813B
Industry Diagnostics & Research
214.79
-3.08%
Mkt Cap 11.064B
Industry Diagnostics & Research
319.28
-0.85%
Mkt Cap 26.399B
Industry Diagnostics & Research
219.23
-0.57%
Mkt Cap 39.944B
Industry Diagnostics & Research
110.92
-0.09%
Mkt Cap 13.687B
Industry Diagnostics & Research
302.09
+0.51%
Mkt Cap 17.92B
Industry Diagnostics & Research
111.19
+1.80%
Mkt Cap 13.654B
Industry Diagnostics & Research
401.19
-0.47%
Mkt Cap 12.43B
Industry Diagnostics & Research
0.0004
0.00%
Mkt Cap 114,597
Industry Diagnostics & Research
1,438.58
+0.04%
Mkt Cap 30.724B
Industry Diagnostics & Research
Statistics: LH
Valuation Measures
As of 6/7/2024
Market Cap
16.57B
Enterprise Value
22.44B
Trailing P/E
42.01
Forward P/E
13.24
PEG Ratio (5yr expected)
0.46
Price/Sales (ttm)
1.38
Price/Book (mrq)
2.08
Enterprise Value/Revenue
1.82
Enterprise Value/EBITDA
16.27
Financial Highlights
Profitability and Income Statement
Profit Margin
3.52%
Return on Assets (ttm)
3.76%
Return on Equity (ttm)
4.37%
Revenue (ttm)
12.3B
Net Income Avi to Common (ttm)
399.2M
Diluted EPS (ttm)
4.68
Balance Sheet and Cash Flow
Total Cash (mrq)
99.3M
Total Debt/Equity (mrq)
75.83%
Levered Free Cash Flow (ttm)
1.05B
Research Analysis: LH
People Also Watch
DGX Quest Diagnostics Incorporated
142.34
-0.21%
WAT Waters Corporation
302.09
+0.51%
UHS Universal Health Services, Inc.
187.53
-0.96%
HOLX Hologic, Inc.
74.51
-0.36%
HUM Humana Inc.
351.80
-1.02%
MCK McKesson Corporation
586.90
+0.13%
HSIC Henry Schein, Inc.
68.51
-0.13%
IQV IQVIA Holdings Inc.
219.23
-0.57%
DVA DaVita Inc.
143.18
-0.46%
HCA HCA Healthcare, Inc.
337.44
+0.18%
MTD Mettler-Toledo International Inc.
1,438.58
+0.04%
XRAY DENTSPLY SIRONA Inc.
27.69
-0.32%
COO The Cooper Companies, Inc.
94.38
-0.91%
RMD ResMed Inc.
210.91
-0.31%
ZBH Zimmer Biomet Holdings, Inc.
113.34
-0.03%
BDX Becton, Dickinson and Company
240.63
+0.19%